UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination

The New England journal of medicine, 2021-06, Vol.384 (22), p.2124-2130

2021

Volltextzugriff (PDF)

Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia

European heart journal, 2021-10, Vol.42 (39), p.4064-4072

2021

Volltextzugriff (PDF)

A Dominant STIM1 Mutation Causes Stormorken Syndrome

Human mutation, 2014-05, Vol.35 (5), p.556-564

2014

Volltextzugriff (PDF)

Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome

Rheumatology (Oxford, England), 2016-07, Vol.55 (7), p.1337-1339

2016

Volltextzugriff (PDF)

Report on 4 cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII

Journal of thrombosis and haemostasis, 2023-10, Vol.21 (10), p.2771-2775

2023

Volltextzugriff (PDF)

Joint health and treatment modalities in Nordic patients with moderate haemophilia A and B – The MoHem study

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-09, Vol.26 (5), p.891-897

2020

Volltextzugriff (PDF)

Health‐related quality of life and physical activity in Nordic patients with moderate haemophilia A and B (the MoHem study)

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-01, Vol.30 (1), p.98-105

2024

Volltextzugriff (PDF)

Haemophilia early arthropathy detection with ultrasound and haemophilia joint health score in the moderate haemophilia (MoHem) study

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-03, Vol.27 (2), p.e253-e259

2021

Volltextzugriff (PDF)

Platelet function testing: Current practice among clinical centres in Northern Europe

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-07, Vol.28 (4), p.642-648

2022

Volltextzugriff (PDF)

Bleeding phenotype of patients with moderate haemophilia A and B assessed by thromboelastometry and thrombin generation

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-09, Vol.27 (5), p.793-801

2021

Volltextzugriff (PDF)

Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) study

Therapeutic advances in hematology, 2023-01, Vol.14, p.20406207231184323-20406207231184323

2023

Volltextzugriff (PDF)

Fixed doses of N8‐GP prophylaxis maintain moderate‐to‐mild factor VIII levels in the majority of patients with severe hemophilia A

Research and practice in thrombosis and haemostasis, 2019-07, Vol.3 (3), p.542-554

2019

Volltextzugriff (PDF)

Hypercoagulability in patients with haematological neoplasia: no apparent initiation by tissue factor

Thrombosis and haemostasis, 2008-06, Vol.99 (6), p.1040-1048

2008

Volltextzugriff (PDF)

The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII in apixaban‐treated patients in vitro

Research and practice in thrombosis and haemostasis, 2017-07, Vol.1 (1), p.49-56

2017

Volltextzugriff (PDF)

Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients

Thrombosis research, 2013-07, Vol.132 (1), p.116-122

2013

Volltextzugriff (PDF)

Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis

Arteriosclerosis, thrombosis, and vascular biology, 1997-04, Vol.17 (4), p.646-653

1997

Volltextzugriff (PDF)

Applicability of the European Society of Cardiology guidelines on management of acute coronary syndromes to people with haemophilia - an assessment by the ADVANCE Working Group

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-11, Vol.19 (6), p.833-840

2013

Volltextzugriff (PDF)

Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review

Drugs in R&D, 2024-08

2024

Volltextzugriff (PDF)

Real-World Clinical Management of Patients with Congenital Hemophilia and Inhibitors: Interim Analysis of the FEIBA Global Outcome Study (FEIBA GO)

Blood, 2020-11, Vol.136 (Supplement 1), p.23-24

2020

Volltextzugriff (PDF)

Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind study

Thrombosis and haemostasis, 2012-11, Vol.108 (5), p.913-922

2012

Volltextzugriff (PDF)

The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor

Thrombosis journal, 2017-02, Vol.15 (1), p.6-6, Article 6

2017

Volltextzugriff (PDF)

Report on four cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII

Journal of thrombosis and haemostasis, 2023-08

2023

Volltextzugriff (PDF)

Home treatment with bypassing products in inhibitor patients: a 7.5-year experience

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-05, Vol.15 (3), p.727-732

2009

Volltextzugriff (PDF)

Real-World Clinical Management of Patients with Hemophilia and Inhibitors: Effectiveness and Safety of aPCC in Patients with >18 Months' Follow-up in the FEIBA Global Outcome Study (FEIBA GO)

Blood, 2019-11, Vol.134 (Supplement_1), p.2418-2418

2019

Volltextzugriff (PDF)

Shear-induced platelet activation and platelet microparticle formation in native human blood

Thrombosis research, 1998-12, Vol.92 (6), p.S33-S41

1998

Volltextzugriff (PDF)

1 – 25 von 134

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(131)
Mit Volltextzugriff
(120)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination

Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia

A Dominant STIM1 Mutation Causes Stormorken Syndrome

Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome

Report on 4 cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII

Joint health and treatment modalities in Nordic patients with moderate haemophilia A and B – The MoHem study

Health‐related quality of life and physical activity in Nordic patients with moderate haemophilia A and B (the MoHem study)

Haemophilia early arthropathy detection with ultrasound and haemophilia joint health score in the moderate haemophilia (MoHem) study

Platelet function testing: Current practice among clinical centres in Northern Europe

Bleeding phenotype of patients with moderate haemophilia A and B assessed by thromboelastometry and thrombin generation

Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) study

Fixed doses of N8‐GP prophylaxis maintain moderate‐to‐mild factor VIII levels in the majority of patients with severe hemophilia A

Hypercoagulability in patients with haematological neoplasia: no apparent initiation by tissue factor

The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII in apixaban‐treated patients in vitro

Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients

Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis

Applicability of the European Society of Cardiology guidelines on management of acute coronary syndromes to people with haemophilia - an assessment by the ADVANCE Working Group

Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review

Real-World Clinical Management of Patients with Congenital Hemophilia and Inhibitors: Interim Analysis of the FEIBA Global Outcome Study (FEIBA GO)

Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind study

The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor

Report on four cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII

Home treatment with bypassing products in inhibitor patients: a 7.5-year experience

Real-World Clinical Management of Patients with Hemophilia and Inhibitors: Effectiveness and Safety of aPCC in Patients with >18 Months' Follow-up in the FEIBA Global Outcome Study (FEIBA GO)

Shear-induced platelet activation and platelet microparticle formation in native human blood

Suchergebnisse filtern